Notice: This company has been marked as potentially delisted and may not be actively trading. Ocata Therapeutics (OCAT) News Today Add Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Morphocell Technologies Appoints Dr. Paul K. Wotton to the Board of DirectorsOctober 30, 2024 | finance.yahoo.comGlobal Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18%August 22, 2024 | finance.yahoo.comAstellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida dealMay 1, 2024 | finance.yahoo.comHuman Embryonic Stem Cells Market Latest Trends, Demand and Precise Outlook- Orthofix International N.V., Sumanas, Ocata TherapeuticsMay 6, 2023 | marketwatch.comTooth Regeneration Market Emerging Trends till 2031May 3, 2023 | marketwatch.comGlobal Tooth Regeneration Market by [2023-2029] with Revenue OutsourcingApril 29, 2023 | marketwatch.comInduced Pluripotent Stem Cells Market by 2031March 27, 2023 | marketwatch.comCombined Therapeutics Expands Board of Directors with Appointments of Biopharma Industry Veterans Paul Wotton, Robert Ruffolo and Kevin F. McLaughlinMarch 8, 2023 | finance.yahoo.comTooth Regeneration Market is Booming Worldwide to Show Significant Growth over the Forecast 2023 to 2028March 6, 2023 | marketwatch.comTooth Regeneration Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028February 25, 2023 | marketwatch.comTooth Regeneration Market Booming With Rising Demands and Massive Opportunities, 2023 - 2028February 22, 2023 | marketwatch.comTooth Regeneration Market: What Strategies Do Companies to Increase Industry Share and Revenue Source?February 15, 2023 | marketwatch.comTooth Regeneration Market Size, Share, Top Region, Key Players, Application, Status and Forecast 2028February 8, 2023 | marketwatch.comTooth Regeneration Market 2023 : Future Trend, Business Strategies, Comprehensive Analysis and Forecast by 2028January 11, 2023 | marketwatch.comWith 3.8% CAGR, Tooth Regeneration Market 2023-2028 Find Out Essential Strategies To Expand The Business And Top Key Players | 88 Pages ReportDecember 22, 2022 | marketwatch.comTooth Regeneration Market Grows Massively, with Industry Entry Investment Feasibility, and Report Conclusion to 2028 | No. 92 Data InsightsDecember 10, 2022 | marketwatch.comEpithelial Stem Cells (Escs) Market Size 2022 Global Analysis Report by Share, Latest Trends, Market Dynamics and Forecast to 2026November 24, 2022 | marketwatch.comHuman Embryonic Stem Cells Market Share, Future Demand, Dynamics, Drivers, Research Methodology by 2026July 30, 2022 | marketwatch.comBinh Duong Water Environment JSC (BWE)June 9, 2022 | investing.comTrias Sentosa Tbk (TRST)June 9, 2022 | investing.comHanyang Eng Co Ltd (045100)June 9, 2022 | investing.comIndo Acidatama Tbk (SRSN)June 9, 2022 | investing.comTooth Regeneration Market Size 2022 Analysis by Competitive Landscape, Key Players, Growth Opportunities, Share and Forecast to 2024 Research ReportApril 13, 2022 | marketwatch.comOcata Therapeutics Inc (OCAT)October 21, 2021 | investing.comHuman Embryonic Stem Cells Market Size, Future Trends, Industry Share, Growth Prospects, Key Players, Market Segments and Forecast 2021-2026September 1, 2021 | marketwatch.com Get Ocata Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OCAT and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. OCAT Media Mentions By Week OCAT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCAT News Sentiment▼0.000.58▲Average News Sentiment OCAT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCAT Articles This Week▼00▲OCAT Articles Average Week Get Ocata Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OCAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCAT) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | SponsoredFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredCritical warning from the mountains of CarolinaNvidia CEO Jensen Huang says Big Tech will spend over $1 trillion on data centers. And that still might not...Weiss Ratings | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocata Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCAT Stock Alerts